Skip to main content

Peer Review reports

From: CB1 receptor antagonist rimonabant protects against chronic intermittent hypoxia-induced renal injury in rats

Original Submission
29 Sep 2020 Submitted Original manuscript
22 Oct 2020 Reviewed Reviewer Report - Natasha Rogers
22 Nov 2020 Reviewed Reviewer Report
13 Dec 2020 Author responded Author comments - Bei Wang
Resubmission - Version 2
13 Dec 2020 Submitted Manuscript version 2
24 Dec 2020 Author responded Author comments - Bei Wang
Resubmission - Version 3
24 Dec 2020 Submitted Manuscript version 3
31 Dec 2020 Author responded Author comments - Bei Wang
Resubmission - Version 4
31 Dec 2020 Submitted Manuscript version 4
1 Jan 2021 Author responded Author comments - Bei Wang
Resubmission - Version 5
1 Jan 2021 Submitted Manuscript version 5
3 Jan 2021 Author responded Author comments - Bei Wang
Resubmission - Version 6
3 Jan 2021 Submitted Manuscript version 6
5 Jan 2021 Reviewed Reviewer Report
13 Jan 2021 Reviewed Reviewer Report - Natasha Rogers
29 Mar 2021 Author responded Author comments - Bei Wang
Resubmission - Version 7
29 Mar 2021 Submitted Manuscript version 7
30 Mar 2021 Author responded Author comments - Bei Wang
Resubmission - Version 8
30 Mar 2021 Submitted Manuscript version 8
31 Mar 2021 Reviewed Reviewer Report - Natasha Rogers
9 Apr 2021 Reviewed Reviewer Report
13 Apr 2021 Author responded Author comments - Bei Wang
Resubmission - Version 9
13 Apr 2021 Submitted Manuscript version 9
14 Apr 2021 Reviewed Reviewer Report
Resubmission - Version 10
Submitted Manuscript version 10
Publishing
14 Apr 2021 Editorially accepted
26 Apr 2021 Article published 10.1186/s12882-021-02362-6

You can find further information about peer review here.

Back to article page